Medtronic, Inc. Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announced today that it has reached the milestone of more than one million sensors for its continuous glucose monitoring (CGM) products manufactured and sold. The recipient of the milestone one millionth sensor was Tim Parker of San Jose, Calif. Parker, diagnosed with type 1 diabetes 11 years ago, has used CGM therapy for two years to help him manage his diabetes.

MORE ON THIS TOPIC